Literature DB >> 2506109

Substitution of serine for arginine in position 162 of TEM-type beta-lactamases extends the substrate profile of mutant enzymes, TEM-7 and TEM-101, to ceftazidime and aztreonam.

E Collatz1, G Tran Van Nhieu, D Billot-Klein, R Williamson, L Gutmann.   

Abstract

TEM-7 is a novel broad-spectrum beta-lactamase (Bla), selected in vivo, with a resistance profile similar to that of TEM-1 and TEM-2, but extended to ceftazidime (Caz) and aztreonam. Nucleotide sequencing revealed that the TEM-7 gene is almost identical with that of TEM-2. There was 1 bp change which would result in the substitution of Ser (TEM-7) for Arg (TEM-2) in amino acid (aa) position 162 (i.e., aa position 139 of the mature enzyme). This substitution, also found in TEM-101, a spontaneous in vitro derivative of TEM-1 selected on Caz, was assumed to be responsible for the extension of the substrate profile. The assumption was verified by exchange of a DNA fragment, carrying the mutation of the TEM-7-coding gene, with the homologous fragment of the TEM-1-coding gene in pBR322. In the three-dimensional model of class-A Bla [Joris et al., Biochem. J. 250 (1988) 313-324], aa 139 is located at the rim of the groove which contains the active center and adjacent to the evolutionarily conserved BoxV. It is speculated that extra free hydroxyl groups in this area may participate in the stabilization of otherwise non-substrate compounds.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2506109     DOI: 10.1016/0378-1119(89)90237-0

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  17 in total

1.  Discrimination of extended-spectrum beta-lactamases by a novel nitrocefin competition assay.

Authors:  G A Papanicolaou; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

2.  Development of "oligotyping" for characterization and molecular epidemiology of TEM beta-lactamases in members of the family Enterobacteriaceae.

Authors:  C Mabilat; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

3.  Identification of amino acid substitutions that alter the substrate specificity of TEM-1 beta-lactamase.

Authors:  T Palzkill; D Botstein
Journal:  J Bacteriol       Date:  1992-08       Impact factor: 3.490

Review 4.  More extended-spectrum beta-lactamases.

Authors:  G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

5.  Updated sequence information for TEM beta-lactamase genes.

Authors:  S Goussard; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

Review 6.  Catalytic properties of class A beta-lactamases: efficiency and diversity.

Authors:  A Matagne; J Lamotte-Brasseur; J M Frère
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

7.  Sequences of CAZ-3 and CTX-2 extended-spectrum beta-lactamase genes.

Authors:  C Chanal; D Sirot; H Malaure; M C Poupart; J Sirot
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

8.  Antibiotic-resistant soil bacteria in transgenic plant fields.

Authors:  Sandrine Demanèche; Hervé Sanguin; John Poté; Elisabeth Navarro; Dominique Bernillon; Patrick Mavingui; Walter Wildi; Timothy M Vogel; Pascal Simonet
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-21       Impact factor: 11.205

9.  Molecular characterization of a cephamycin-hydrolyzing and inhibitor-resistant class A beta-lactamase, GES-4, possessing a single G170S substitution in the omega-loop.

Authors:  Jun-ichi Wachino; Yohei Doi; Kunikazu Yamane; Naohiro Shibata; Tetsuya Yagi; Takako Kubota; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

10.  Novel gyrA point mutation in a strain of Escherichia coli resistant to fluoroquinolones but not to nalidixic acid.

Authors:  E Cambau; F Bordon; E Collatz; L Gutmann
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.